The effectiveness of malaria camps as part of the malaria control program in Odisha, India.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 12 2023
Historique:
received: 10 01 2023
accepted: 30 10 2023
medline: 29 12 2023
pubmed: 29 12 2023
entrez: 28 12 2023
Statut: epublish

Résumé

Durgama Anchalare Malaria Nirakaran (DAMaN) is a multi-component malaria intervention for hard-to-reach villages in Odisha, India. The main component, malaria camps (MCs), consists of mass screening, treatment, education, and intensified vector control. We evaluated MC effectiveness using a quasi-experimental cluster-assigned stepped-wedge study with a pretest-posttest control group in 15 villages: six immediate (Arm A), six delayed (Arm B), and three previous interventions (Arm C). The primary outcome was PCR + Plasmodium infection prevalence. The time (i.e., baseline vs. follow-up 3) x study arm interaction term shows that there were statistically significant lower odds of PCR + Plasmodium infection in Arm A (AOR = 0.36, 95% CI = 0.17, 0.74) but not Arm C as compared to Arm B at the third follow-up. The cost per person ranged between US$3-8, the cost per tested US$4-9, and the cost per treated US$82-1,614, per camp round. These results suggest that the DAMaN intervention is a promising and financially feasible approach for malaria control.

Identifiants

pubmed: 38155156
doi: 10.1038/s41598-023-46220-x
pii: 10.1038/s41598-023-46220-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

22998

Subventions

Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089676
Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089676
Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089676
Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089676
Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089676
Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089676
Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089676
Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089676
Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089676

Informations de copyright

© 2023. The Author(s).

Références

World malaria report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. ( Geneva, 2021).
World malaria report 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. (2022).
National Vector Borne Disease Control Program, D. G. o. H. S., Ministry of Health and Family Welfare, Government of India. (2020).
Rajvanshi, H. et al. Learnings from two independent malaria elimination demonstration projects in India. Trans. R. Soc. Trop. Med. Hyg. (2021)
Pradhan, M. M. et al. Comprehensive case management of malaria: Operational research informing policy. J. Vect. Borne Dis. 56, 56–59 (2019).
doi: 10.4103/0972-9062.257776
Bal, M. et al. Assessment of effectiveness of DAMaN: A malaria intervention program initiated by Government of Odisha, India. PLoS ONE 15, e0238323 (2020).
doi: 10.1371/journal.pone.0238323 pubmed: 32898853 pmcid: 7478908
Ompad, D. C. et al. The effectiveness of malaria camps as part of the Durgama Anchalare Malaria Nirakaran (DAMaN) program in Odisha, India: Study protocol for a cluster-assigned quasi-experimental study. Glob. Health Action 14, 1886458 (2021).
doi: 10.1080/16549716.2021.1886458 pubmed: 33866961 pmcid: 8183513
National Vector Borne Disease Control Programme. (2007).
Department of Health & Family Welfare (India). National Vector Borne Disease Control Programme (NVBDCP). https://health.odisha.gov.in/NVBDCP.asp . (Accessed 16 Dec 2021).
Pradhan, M. M. & Meherda, P. K. Malaria elimination drive in Odisha: Hope for halting the transmission. J. Vect. Borne Dis. 56, 53–55 (2019).
doi: 10.4103/0972-9062.257775
Kim, S., Luande, V. N., Rocklov, J., Carlton, J. M. & Tozan, Y. A Systematic Review of the Evidence on the Effectiveness and Cost-Effectiveness of Mass Screen-and-Treat Interventions for Malaria Control. Am. J. Trop. Med. Hyg. 105, 1722–1731 (2021).
doi: 10.4269/ajtmh.21-0325 pubmed: 34491213 pmcid: 8641306
World Health Organization. Global Health Expenditure database, https://apps.who.int/nha/database (2021).
Service, E. N. in The New Indian Express (2022).
Demas, A. et al. Applied genomics: data mining reveals species-specific malaria diagnostic targets more sensitive than 18S rRNA. J. Clin. Microbiol. 49, 2411–2418 (2011).
doi: 10.1128/JCM.02603-10 pubmed: 21525225 pmcid: 3147814
Osier, F. H. et al. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol. 29, 387–394 (2007).
doi: 10.1111/j.1365-3024.2007.00951.x pubmed: 17650180 pmcid: 1976398
Osier, F. H. et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: Mechanism in human immunity and a correlate of protection against malaria. BMC Med. 12, 108 (2014).
doi: 10.1186/1741-7015-12-108 pubmed: 24980799 pmcid: 4098671
Elliott, S. R. et al. Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep. 6, 100 (2014).
doi: 10.12703/P6-100 pubmed: 25580254 pmcid: 4229730
Achan, J. et al. Serologic markers of previous malaria exposure and functional antibodies inhibiting parasite growth are associated with parasite kinetics following a plasmodium falciparum controlled human infection. Clin Infect Dis 70, 2544–2552 (2020).
doi: 10.1093/cid/ciz740 pubmed: 31402382
Wu, L. et al. Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration. BMC Med. 18, 331 (2020).
doi: 10.1186/s12916-020-01785-6 pubmed: 33183292 pmcid: 7664049
Wu, L. et al. Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia. BMC Med. 18, 304 (2020).
doi: 10.1186/s12916-020-01724-5 pubmed: 32972398 pmcid: 7517687
Wu, L. et al. Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. Wellcome Open Res. 4, 26 (2019).
doi: 10.12688/wellcomeopenres.14950.1 pubmed: 32518839
Helb, D. A. et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc. Natl. Acad. Sci. USA 112, E4438-4447 (2015).
doi: 10.1073/pnas.1501705112 pubmed: 26216993 pmcid: 4538641
Indian Academy of Pediatrics Growth Charts, C. et al. Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children. Indian Pediatr 52, 47–55 (2015)
Malaria, S. Trop Med Int Health 19, 7–131 (2014).
doi: 10.1111/tmi.12313_2
Tang, A. M. et al. Determining a global mid-upper arm circumference cut-off to assess underweight in adults (men and non-pregnant women). Public Health Nutr 23, 3104–3113 (2020).
doi: 10.1017/S1368980020000397 pubmed: 32799964 pmcid: 10200499
Van Tonder, E. et al. Mid-upper arm circumference (MUAC) as a feasible tool in detecting adult malnutrition. South Afr. J. Clin. Nutrit. 32, 93–98 (2019).
doi: 10.1080/16070658.2018.1484622
WHO. Guidelines for an Integrated Approach to the Nutritional Care of HIV-Infected Children (6 Months-14 Years). (2009).
Roberfroid, D. et al. Utilization of mid-upper arm circumference versus weight-for-height in nutritional rehabilitation programmes: A systematic review of evidence. WHO commissioned white paper (2013). https://www.who.int/nutrition/publications/guidelines/updates_management_SAM_infantandchildren_review1.pdf .
Drummond, M. F., Sculpher, M. J., Torrance, G. W., O’Brien, B. J. & Stoddart, G. L. Methods for the Economic Evaluation of Health Care Programmes. (Oxford University Press, 2005).
Secretary, P. (ed Health &Family Welfare Department) (National Vector Borne Disease Control Programme, 2016–2020).
Fund, I. M. in Exchange Rates (2020).
Snijders, T. A. B. & Bosker, R. J. Multilevel analysis : an introduction to basic and advanced multilevel modeling. 2nd edn, (Sage, 2012).
McNeish, D. & Stapleton, L. M. Modeling clustered data with very few clusters. Multivar. Behav. Res. 51, 495–518 (2016).
doi: 10.1080/00273171.2016.1167008
Ruhamyankaka, E. et al. ClinEpiDB: An open-access clinical epidemiology database resource encouraging online exploration of complex studies. Gates Open Res. 3, 1661 (2019).
doi: 10.12688/gatesopenres.13087.1 pubmed: 32047873

Auteurs

Danielle C Ompad (DC)

School of Global Public Health, New York University, New York, NY, 10003, USA. dco2@nyu.edu.

Timir K Padhan (TK)

Department of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, 769042, India.

Anne Kessler (A)

Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, 10003, USA.

Yesim Tozan (Y)

School of Global Public Health, New York University, New York, NY, 10003, USA.

Abbey M Jones (AM)

School of Global Public Health, New York University, New York, NY, 10003, USA.

Anna Maria van Eijk (AM)

Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, 10003, USA.
Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Steven A Sullivan (SA)

Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, 10003, USA.

Mohammed A Haque (MA)

Department of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, 769042, India.

Madan Mohan Pradhan (MM)

Department of Health and Family Welfare, State Vector Borne Disease Control Programme, Bhubaneswar, Odisha, 751001, India.

Sanjib Mohanty (S)

Department of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, 769042, India.

Jane M Carlton (JM)

School of Global Public Health, New York University, New York, NY, 10003, USA.
Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, 10003, USA.
Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Global Public Health, Baltimore, MD, 21205, USA.

Praveen K Sahu (PK)

Department of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, 769042, India.

Classifications MeSH